3 results on '"null Kyu Chang Won"'
Search Results
2. Author response for 'Efficacy and safety of enavogliflozin, a novel <scp>SGLT2</scp> inhibitor, in Korean people with type 2 diabetes: a 24‐week, multicentre, randomised, double‐blind, placebo‐controlled, phase <scp>III</scp> trial'
3. Author response for 'Anagliptin twice‐daily regimen improves glycemic variability in subjects with type 2 diabetes: <scp>Double‐Blind</scp> , Randomized Controlled Trial'
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.